Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04266912
Recruitment Status : Recruiting
First Posted : February 12, 2020
Last Update Posted : November 19, 2021
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 11, 2024
Estimated Study Completion Date : September 11, 2024